Cocrystal Pharma, Inc.COCPNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.17
↑ 96% vs avg
Percentile
P79
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-26.83
Historical baseline
PeriodValueYoY Change
2024-1.17-27.2%
2023-0.92-125.8%
2022-0.41+90.3%
2021-4.23+47.9%
2020-8.11-2033.1%
2019-0.38+81.5%
2018-2.06+99.1%
2017-236.14-6319.3%
2016-3.68+67.2%
2015-11.20-